Hubert L. Allen, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 1,074 shares at $39.07 ($42K) on 2014-02-18, disclosed to the SEC on 2014-02-19.
Scheduled sale ($42k) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.81 | 395 | $15K | 36.7% |
| 2 | $38.81 | 346 | $13K | 32.1% |
| 3 | $39.07 | 333 | $13K | 31.1% |
| Total | $38.89 avg | 1,074 | $42K | 100% |
| Filing → |
| ABT | SELL | 2024-03-04 | $202K | — | Filing → |
| ABT | SELL | 2023-03-02 | $215K | — | Filing → |
| ABT | SELL | 2022-03-02 | $343K | — | Filing → |